Best of ASCO - 2014 Annual Meeting

 

Welcome

Quality of Care/Quality Improvement

Health Services Research, Clinical Informatics, and Quality of Care

2018 ASCO Annual Meeting

Sort by: title abstract no. first author
ABSTRACT TITLEFIRST AUTHORABSTRACT NO.
CYP2C19-guided voriconazole prophylaxis in neutropenic AML patients.

James Kevin Hicks

6594

A claims data analysis of single institution for comorbidity among various types of cancer.

Kazuhiro Araki

e18843

A collaborative physician engagement strategy to reduce oncology care variation across a clinically integrated network.

Trever Bradley Burgon

e18807

A conversation approach based on shared goal-setting and shared decision-making for nurses in cancer aftercare: A developmental study.

Jolanda H Friesen

e18878

A nationwide analysis of palliative care service utilization in hospitalized metastatic cancer patients.

Kaushal Parikh

6602

Adherence to oral anticancer medications after implementation of an ambulatory adherence program at a large urban academic hospital.

Marjorie Adams Curry

6591

Adverse events as a cause of unscheduled hospitalizations for solid tumor oncology patients receiving chemotherapy.

Chris I. Wong

e18815

Ambulatory cancer care electronic symptom self-reporting (ACCESS) for surgical patients: A randomized controlled trial.

Cara Stabile

TPS6622

An internet-based survey of factors influencing patients’ satisfaction score and factors leading to discontinuation of treatment in lung cancer patients in China.

Weini Qiu

e18871

Assessing indicators of glioblastoma care quality in neuro-oncology centers: Baseline results of a pilot initiative.

Gabriel Zada

e18880

Assessment and treatment of breakthrough cancer pain in Spain: A self-audit study.

Rafael Lopez

e18785

Automated concordance estimation between radiology and pathology reports.

Vadiraj Hombal

e18862

Balancing the risk and benefit of adjuvant chemotherapy for early breast cancer: A retrospective cohort study in New South Wales (NSW), Australia.

Hanna E Tervonen

e18841

Cancer patient-reported knowledge and preferences for liquid biopsies and blood biomarkers at a comprehensive cancer centre.

Min Joon Lee

6587

Cannabis in cancer patients [CP] to improve quality of life [QOL] and cancer related symptoms [CRS]: Illinois Cancer Care cannabis education and clinical analysis.

Shawn Michael Seibert

e18812

Changes in quality of life at baseline, 6, and 12-months of the “Joven y Fuerte” prospective cohort pilot phase.

Cynthia Mayte Villarreal-Garza

e18854

Chinese doctors' practices regarding fertility preservation in cancer patients.

Yumei Lin

e18864

Choice of radioactive iodine treatment for thyroid cancer: Results from a population-based survey.

Lauren P. Wallner

e18781

Chronic myeloid leukemia among veterans from 2006-2015: Trends in utilization of tyrosine kinase inhibitors.

Catherine Chanfreau

e18832

Classifying lung cancer stage from health care claims with a clinical algorithm or a machine-learning approach.

Gabriel A. Brooks

6589

Comparison of legacy quality of life measures with the electronic quality of life measuring system (NIH PROMIS) in glioblastoma patients.

Tobias Walbert

e18823

Developing educational interventions and clinical tools to improve risk-based prevention and management of tumor lysis syndrome (TLS).

Mitchell S. Cairo

e18811

Development of a dashboard for end-of-life care at an academic hospital.

Kerin B. Adelson

6590

Do patients with an ECOG of 3 or 4 receive anti-cancer therapy after discharge from subacute rehabilitation?

Muhammad Azeem Khan

e18856

Does the risk of emergency department visits and hospitalizations during systemic therapy for cancer influence patients’ decisions regarding treatment?

Cameron Phillips

e18803

Does training oncologists to have goals of care discussions affect healthcare utilization among patients with advanced cancer?

Nina A. Bickell

6595

Does training oncologists to have goals of care discussions increase and improve the quality of GoC discussions with advanced cancer patients?

Nina A. Bickell

6597

Drug profile interactions and importance of multiprofessional pharmacotherapeutic follow-up of oncology outpatients.

Nathalia Fonseca Gamboa

e18847

Effect of pegfilgrastim on-body injector (OBI) on cancer care: A real-world health system and interrupted time series analysis.

Junji Lin

e18859

Effects of enzalutamide and abiraterone on patients physical, social and emotional function: Result of a prospective patients reported outcome tool.

Prantik Das

e18857

Efficacy of trastuzumab for HER-2 positive breast cancer in a real-life setting: A decade of experience under national treatment coverage regulations.

Natalia Camejo

e18789

Enhancing bladder cancer (BC) care through clinician and patient education.

Hamsa Jaganathan

e18834

Enoxaparin use during chemotherapy induced thrombocytopenic phase in cancer patients with venous thromboembolism.

Jiaxiang Liu

e18852

Estimated glomerular filtration rate: Do we measure the real renal function or are we still groping in the dark?

Francesco Trevisani

e18809

Evaluating the use of prophylactic cranial irradiation in small cell lung cancer.

Asaad Trabolsi

e18838

Evaluation of patient characteristics, perceptions and experience in cancer clinical trial in National Cancer Center in China: Identifying factors affecting subjects’ satisfaction and stress.

Shiyu Jiang

e18802

Examining clinician confidence in the management of breast cancer (BC) based on subtype.

Hamsa Jaganathan

e18835

Fasting vs. postprandial evaluation of iron deficiency anemia in cancer.

Satish Maharaj

e18876

FDA review, CMS coverage, and NIH information for next generation sequencing.

Katherine B. Szarama

e18798

Granulocyte colony stimulating factor (G-CSF) from guidelines to efficiency: A single institution study.

Hossam Ragab Mohammad Abdulkhalek

e18837

Hospital admissions due to immuno-oncology therapy associated toxicity: A retrospective analysis at two tertiary oncology centres.

Michael J Allen

e18805

Identifying and interpreting actionable molecular alterations from next-generation sequencing results in the community: A Sarah Cannon molecular cancer conference.

Holli Hutcheson Dilks

6601

Impact of a community-based molecular cancer conference on physician practice and clinical care.

Andrew McKenzie

e18774

Impact of electronic decision support and targeted educational intervention to increase adherence with ASCO Choosing Wisely breast cancer staging guideline.

Dedeepya Konuthula

e18826

Impact of NET MDT on overall survival within NETwerk, a collaborative ENETS Center of Excellence.

Timon Vandamme

e18861

Implementation of active pharmaceutical search for adverse drug reactions.

Marcos Coelho Simões Travassos Soares

e18825

Implementation of algorithm to guide CSF flow cytometry testing in hematological malignancies.

Bernard Tawfik

e18792

Implementation of an oral chemotherapy adherence tracking program at a medically underserved comprehensive community cancer center.

Abhinav Binod Chandra

e18873

Implementation of dietary education within a multidisciplinary team approach to improve treatment accuracy and efficiency in prostate cancer external beam radiation therapy.

Taylor L Evans

6599

Implementing improved pathologic nodal (pN) staging during non-small cell lung cancer (NSCLC) resection: A population-based study.

Meredith Ray

e18791

Importance of pharmacovigilance in the analysis of the profile of hospitalized patients for treatment toxicity.

Nathalia Fonseca Gamboa

e18846

Improvement of EGFR testing under multidisciplinary care: A retrospective chart analysis.

Margaret Griffin Crawford

e18874

Improving advance directive completion rates on an inpatient oncology unit.

Navin Dhingra

e18829

Improving documentation of pain and constipation management within the cancer center of a large public healthcare network.

Giselle Dutcher

6596

Improving safety and adherence of oral chemotherapy.

George Shahin

e18788

Improving the process for assessing patients (pts) emotional well-being and ensuring appropriate and timely interventions.

Sirisha Karri

e18800

Incidence of hypomagnesemia in a pertuzumab-treated population.

Jonathan Thomas

e18820

Inpatient utilization of naloxone at a tertiary cancer center.

Shalini Dalal

e18830

Integration of ongoing quality assurance measures in colorectal cancer survivorship care plans.

Samantha S. Sigurdson

e18858

Investigating strategies to improve clinical trial opportunities in oncology in New Zealand (INSIGHT).

Yeojeong So

e18851

Is cancer associated thrombosis (CAT) a neglected issue? Greek management of thrombosis (GMaT) in cancer patients.

Nikolaos Tsoukalas

e18868

Is hospital patient safety culture relevant?

James N Masciale

e18775

Man vs machine: Are febrile neutropenia rates different using an in-clinic vs on-body injection?

Hank Ng

e18867

Management problems associated with the length of hospital stays in medical oncology departments in Italy: The experience of the Reggio Emilia Clinical Cancer Center.

Mario Larocca

e18842

Meaningful application of precision oncology.

Jasmine Kamboj

e18806

National Comprehensive Cancer Network (NCCN) guideline compliance for lung cancer in a community teaching hospital.

Sufana Shikdar

e18860

National trends in admissions for potentially preventable conditions among patients with metastatic solid tumors, 2004-2014.

Robert Michael Daly

e18813

Oncological urgent care department: Planning for the unexpected.

Jessica Livneh

e18772

One way to shrink oncology patients’ emergency room length of stay.

Mohamed M. Hegazi

e18850

Opioid prescriptions after breast cancer surgery: Perception and reality.

Ko Un Park

e18799

Opioid use in long term cancer survivors.

Lisa Catherine Barbera

6520

Opportunities for interventions to reduce the financial toxicity of treatment for childhood cancer.

Rebecca Lobb

e18797

Patient blood management program in oncological surgery: A multicenter prospective study.

Alessandro Bonini

e18793

Patient-clinician communication and oral chemotherapy adherence.

Jennifer Elston Lafata

e18849

Perception and opinions of health professionals of an Italian academic hospital about complementary and alternative medicine in oncology.

Claudia Bozza

e18865

Physicians’ documented performance of shared decision-making with chronic lymphocytic leukemia patients.

Anthony R. Mato

e18786

Predictors of venous thromboembolism among cancer inpatients: A predictive model.

Shiva Shrotriya

e18824

Preliminary findings from a pilot program to provide access to low-dose CT screening for high-risk patients.

Katherine Sharpe

e18844

Prevalence of clinically relevant drug-drug interactions in patients enrolled in NCTN clinical trials.

Lauren A Marcath

e18819

Prevalence of HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) among newly diagnosed cancer patients treated in academic and community oncology practices: SWOG S1204.

Scott David Ramsey

6600

Process improvement and cost savings in cancer care through the utilization of technology in tumor boards.

Lijo Simpson

e18779

Prolonged treatment of patients with cancer associated thromboembolism (CAT). mapping of treatment landscape based on a German statutory health insurance (SHI) claims data analysis [CERTIFICAT].

Albrecht Kretzschmar

e18855

Prospective registration of cancer clinical trials in India.

Sean Butterbaugh

e18863

Prospective study on oral alkalization in patients receiving high dose methotrexate.

Daniel Reed

e18804

Quality improvement program in radiation oncology: Understanding patient hospitalizations, treatment breaks, and weight loss in patients receiving radiotherapy.

Varun Chowdhry

e18840

Quality improvement project for prevention of infusion related reactions of daratumumab therapy in multiple myeloma patients.

Vishal Jindal

e18877

Quality of care outcomes among breast cancer patients treated with cancer care pathway regimens.

Santosh Gautam

e18827

Quality of life and performance capacity in patients with breast cancer and patients with gastro-intestinal stromal tumors (GIST).

Matias Chacon

e18881

Rates of hepatitis b screening and prophylactic treatment before immunosuppressive therapy in hematological malignancies.

Ethan Tobias

e18845

Real world of infusion related reactions in an oncology outpatient clinic.

Beatriz Bernardez

e18872

Reviewing the pattern of care and treatment effectiveness for glioblastomas, a university affiliated community hospital experience.

Steven Jubelirer

e18866

Roadmap for supportive care according to patients' perspectives.

François Eisinger

e18821

Safety and outcome evaluation on cancer patients treated with immune checkpoint inhibitors either from standard of care or clinical trial enrollment.

Diego Felipe Cabrera Fernandez

e18782

Safety and tolerability of cancer drugs studied in phase 3 randomized controlled trials (RCTs) over the last decade.

Domen Ribnikar

6588

Safety profile and reduced observation time in outpatients using subcutaneous Herceptin.

Fabiano Hosken Pombo

e18848

Screening for new primary cancers in patients with metastatic breast cancer: A provincial analysis of the Choosing Wisely Canada recommendations.

Megan E. Tesch

e18817

Social media usage within the cancer community of northern New England.

Lukas P Emery

e18839

Standardization of inpatient CPR/code status discussions and documentation within the division of hematology-oncology at UPMC Shadyside.

Rachel Rodenbach

e18776

Sustaining change and defining the patient experience: A systemwide initiative to re-evaluate goals for timely patient navigation through medical oncology and infusion in a comprehensive cancer center.

David L Crosby

e18875

The future of precision medicine, strengths and weaknesses: An expert position paper.

Vicente Guillem Porta

e18879

The impact of the ASCO Choosing Wisely campaign for breast and prostate cancer on physician behavior.

Danielle Lee Rodin

6592

Treatment pattern and unmet need in adults with Philadelphia positive (Ph+) relapsed or refractory (R/R) B-cell precursor (BCP) acute lymphoblastic leukemia (ALL) in EU-5 countries.

Xinke Zhang

e18869

Use of hypofractionated radiotherapy for early stage breast cancer after implementation of evidence-based clinical guidelines.

Santosh Gautam

6593

Use of molecular testing and EGFR targeted medications for colorectal cancer at VA Hospitals.

Daniel Jacob Becker

e18814

Use of QT interval prolonging drugs (QT drugs) and electrocardiogram (ECG) monitoring in patients (pts) receiving first-line anti-cancer systemic therapy (tx): A population-based analysis.

Rossanna C. Pezo

6598

Using patient satisfaction to predict readmissions in cancer patients.

Lisa Diamond

e18870

Utility and factors associated with imaging early stage breast cancer: Are we choosing wisely?

Ana Velazquez Manana

e18787

Utilization rates of enoxaparin and heparin in venous thromboembolism prophylaxis after education and electronic order change at a single institution: A quality improvement study.

Linda Phuong Hoang

e18836

Variability of pelvic MRI performance in a prospective multicenter rectal cancer trial NCCTG N1048 (Alliance).

Marc Jeffrey Gollub

e18783

Virtual metastatic breast multidisciplinary meeting: The next step in personalised medicine.

Helen Winter

e18794

Voice of cancer patients: Analysis of use and efficacy of yoga and meditation in cancer patient.

Sangeeta Aggarwal

e18801

What do patients want to know when selecting a hospital for cancer care?

Allison Nicole Lipitz Snyderman

e18810